Approximately 9,500 new patients are diagnosed with cancer of the biliary tract (the gallbladder and bile ducts) each year in the United States. This is the second most common type of cancer to involve the region of the liver, following cancer of the hepatocytes (hepatocellular carcinoma).
Each year in the USA, 3600 patients will die of biliary tract cancer, accounting for approximately 1% of all deaths from cancer. Biliary tract cancers are notoriously challenging to diagnose and treat.
The Johns Hopkins Medical Institutions is a leader in the treatment and investigative study of biliary tract cancer. We have created this Web site to give patients and physicians access to the latest clinical and research developments related to this disease, as well as to the multidisciplinary team assembled here to fight biliary tract cancer.
© Copyright 2002-2022 Johns Hopkins University All Rights Reserved